Data Horizon Co Ltd

Data Horizon operates with a highly leveraged capital structure, as evidenced by a debt-to-equity ratio of 21.7, indicating significant reliance on debt financing. The company holds JPY 1.22 billion in cash and equivalents, but this is offset by JPY 4.81 billion in long-term debt, resulting in a negative net cash position. The liquidity risk is moderate, with a current ratio of 1.24, suggesting the company can cover its short-term liabilities but with limited buffer. Profitability metrics are severely negative, with a return on equity of -13.37% and a return on assets of -0.49%, both well below the industry median for healthcare technology firms. The company reported a net loss of JPY 2.96 billion and an operating loss of JPY 2.98 billion, indicating a lack of operational efficiency and a failure to generate positive returns on invested capital. The company's revenue is concentrated in its Medical-related Information segment, which accounts for the majority of its operations. Geographically, the firm is entirely focused on the Japanese market, with no disclosed international revenue. This concentration increases exposure to local economic and regulatory shifts, particularly in the healthcare sector. Growth prospects are constrained, with no disclosed revenue growth in the current fiscal year and no forward-looking guidance provided. The company's operating cash flow is negative at JPY -1.88 billion, and capital expenditures of JPY -591.68 million suggest ongoing investment in infrastructure, though not at a rate sufficient to offset losses. Risk factors include a high debt load, negative net income, and a lack of positive cash flow generation. The company has not disclosed any dilution events in the near term, and the risk of dilution remains low. However, the negative operating performance and high leverage increase the likelihood of future capital-raising activities, which could dilute existing shareholders. Recent events include the filing of its latest 10-K, which outlines the company's financial challenges and operational focus. No significant earnings calls or management commentary have been disclosed in the past quarter, limiting insight into strategic direction or near-term operational improvements.